What is the significance of a B-type natriuretic peptide (BNP) level of 168 pg/mL and what are the recommended next steps?

BNP Level of 168 pg/mL: Intermediate Zone Requiring Further Cardiac Evaluation

A BNP of 168 pg/mL falls in the "gray zone" where heart failure is possible but not confirmed—you must proceed with echocardiography and comprehensive clinical assessment to determine if cardiac dysfunction is present, while actively considering alternative diagnoses including chronic LV dysfunction, pulmonary disease, or pulmonary embolism. 1

Interpretation Framework

Diagnostic Thresholds

Based on established guidelines, BNP levels are stratified as follows 1:

• <100 pg/mL: Heart failure effectively ruled out (90% sensitivity, 76% specificity)
• 100-500 pg/mL: Intermediate/gray zone—heart failure possible but uncertain
• >500 pg/mL: Heart failure very likely

Your patient's BNP of 168 pg/mL places them squarely in the intermediate range, where diagnostic accuracy is limited and additional testing is mandatory.

What This Level Means

The 168 pg/mL value indicates cardiac stress but lacks specificity. While this level excludes the diagnosis being "very likely," it also exceeds the threshold to confidently rule out heart failure 2, 3. The sensitivity at this intermediate range is only modest (approximately 43-68% depending on the specific threshold used), and specificity is similarly limited (74-75%) 2.

Immediate Next Steps

1. Obtain Echocardiography Within 2-6 Weeks

Echocardiography is non-negotiable at this BNP level 4. The timing depends on clinical acuity:

• Within 2 weeks if the patient has prior myocardial infarction or acute symptoms
• Within 6 weeks if outpatient with stable symptoms 4

The echocardiogram must assess:

• Left ventricular ejection fraction (to differentiate HFrEF vs HFpEF)
• Left ventricular end-diastolic pressure indicators (E/e' ratio >15 suggests elevated filling pressures) 5
• Right ventricular function
• Valvular abnormalities
• Chamber dimensions and wall thickness

2. Clinical Context Assessment

Evaluate specific factors that influence BNP interpretation:

Age considerations: BNP naturally increases with age, so a level of 168 pg/mL may be more significant in a younger patient (<50 years) than in an elderly patient 1

Body mass index:

• If BMI >35 kg/m²: This BNP level is MORE concerning, as obesity falsely lowers BNP. The adjusted threshold for obese patients is 54-55 pg/mL to rule out heart failure 2, 3
• A BNP of 168 pg/mL in an obese patient may represent more severe cardiac dysfunction than the number suggests

Renal function:

• If GFR <60 mL/min/1.73 m²: BNP is elevated independent of heart failure status. The rule-out threshold increases to 200-225 pg/mL in renal dysfunction 2, 1
• If creatinine is elevated, this BNP may be less specific for cardiac disease

Gender: Women have higher baseline BNP levels than men 1

3. Consider Alternative Diagnoses

At this intermediate BNP level, actively investigate 1:

Cardiac causes beyond heart failure:

• Chronic LV dysfunction without acute decompensation
• Diastolic dysfunction (BNP elevated but typically lower than systolic dysfunction) 1
• Atrial fibrillation (causes BNP elevation independent of heart failure)
• Acute coronary syndrome
• Valvular disease (especially mitral regurgitation)
• Right ventricular dysfunction

Non-cardiac causes:

• Pulmonary embolism (causes RV strain and BNP elevation)
• Pulmonary hypertension
• Chronic obstructive pulmonary disease
• Sepsis (elevates BNP through multiple mechanisms) 6, 7

Clinical Pitfalls to Avoid

False Reassurance

Do not assume heart failure is absent based on this level. The intermediate zone has insufficient negative predictive value to exclude the diagnosis 8. Approximately 25-30% of patients with heart failure have BNP levels in this range, particularly those with:

• HFpEF (preserved ejection fraction)
• Obesity
• Flash pulmonary edema (insufficient time for BNP release) 1

Overdiagnosis

Do not diagnose heart failure based on BNP alone. At 168 pg/mL, specificity is only 74-75%, meaning 25-26% of patients without heart failure will have levels in this range 2. Echocardiographic confirmation is essential.

Ignoring Confounders

The most common error is failing to adjust interpretation for:

• Obesity (lowers BNP disproportionately)
• Renal failure (raises BNP independent of cardiac status)
• Acute illness (sepsis, PE raise BNP acutely)

Prognostic Implications

Even in the absence of confirmed heart failure, a BNP of 168 pg/mL carries prognostic significance. This level indicates increased cardiovascular risk and predicts higher mortality compared to levels <100 pg/mL 3, 9. The 3-year mortality risk associated with BNP levels in this range approaches 15-20%, regardless of whether formal heart failure is diagnosed 9.

Summary Algorithm

1. Confirm clinical context: Assess symptoms (dyspnea, orthopnea, edema), examine for rales, elevated JVP, peripheral edema
2. Check confounders: BMI, creatinine/GFR, age, presence of AF
3. Order echocardiography: Within 2-6 weeks based on acuity
4. Consider alternative diagnoses: Obtain chest X-ray, consider CT pulmonary angiography if PE suspected, check troponin if ACS possible
5. Refer to cardiology if echocardiogram shows:
   • LVEF <50%
   • E/e' ratio >15
   • Significant valvular disease
   • Elevated pulmonary pressures

The combination of BNP with echocardiographic E/e' ratio provides superior diagnostic accuracy (AUC 0.904) compared to either test alone 1, 5, making this combined approach the standard of care for intermediate BNP values.